Case Summary:      

We are pleased to share the success story of an EB1A (Alien of Extraordinary Ability) approval for a postdoctoral fellow from Brazil whose work focuses on cancer genetics, gene expression, and molecular biology. At the time of filing, the client held a research position and had made influential contributions to his field. With a strong record of publications, citations, and peer review service, NAILG prepared and filed his EB1A petition, which was approved after an RFE response.

Research with Substantial Merit and National Importance

The client’s research investigates molecular mechanisms underlying disease progression and treatment, particularly in the context of environmental exposures and gene regulation in cancer. His original findings have offered insight into the impact of occupational and environmental factors on cancer vulnerability, the identification of biomarkers for liver cancer and obesity, and the role of transcription factors in overcoming treatment resistance. His work supports advancements in public health, toxicology, and cancer therapies and aligns with national goals in biomedical research.

Well Positioned to Advance the Proposed Endeavor

The petition demonstrated that the client is well-positioned to further his research within the U.S. scientific community. At the time of filing, he had authored 27 peer-reviewed publications in leading journals such as Journal of Hepatology, Molecular Cell, and Trends in Cancer. He had received 255 citations from researchers in over 30 countries, reflecting the broad reach and impact of his work. In addition, he had conducted at least 15 peer reviews for high-impact journals, further establishing his recognition as a field expert.

Demonstrating the Client’s Significance

NAILG supported the petition by presenting concrete evidence that the client’s work has been adopted by global researchers in fields such as hepatology, oncology, and environmental health. For example, his methods have been used to investigate the genotoxic effects of pesticides, the role of nitric oxide in liver cancers, and the regulation of microRNAs linked to metabolic diseases. These examples illustrate that his contributions are not only original but have been instrumental in propelling research by others.

Expert Endorsement of the Client’s Impactful Research:

To further support the petition, we included six letters of recommendation from researchers based in North and South America and Europe. These experts, including five independent recommenders, confirmed the originality, applicability, and continued influence of the client’s work.

One recommender noted:

“[Client]’s findings have not only shed light on overcoming therapy resistance in breast cancer but are paving the way for the development of novel therapeutic strategies applicable to other diseases and contexts.”

Strong Petition Strategy and Swift Approval:

Despite an RFE issued shortly after filing, our team at NAILG presented a focused and compelling response that emphasized the client’s top-tier contributions and the extensive international adoption of his work. USCIS approved the EB1A petition just three months and eight days after filing. This result demonstrates the power of a well-prepared petition and the importance of tailoring an evidentiary presentation to the client’s unique strengths.